Vergoeding 2016-2020 voor ATC-subgroep C09CA : Angiotensine-ii-antagonisten

  • Raming voor de totale Zvw-populatie
  2016 2017 2018 2019 2020
C09CA01 Losartan (Cozaar ®) 2.367.000 2.564.900 3.059.000 5.492.000 5.652.200
C09CA02 Eprosartan (Teveten ®) 408.410 378.180 363.030 113.320 46.900
C09CA03 Valsartan (Diovan ®) 3.109.200 3.226.000 3.565.400 2.696.100 2.509.300
C09CA04 Irbesartan (Aprovel ®) 2.985.900 2.529.500 2.643.100 4.279.300 4.178.600
C09CA06 Candesartan (Atacand ®) 1.109.000 1.086.200 1.210.000 1.776.500 1.983.800
C09CA07 Telmisartan (Micardis ®) 898.830 798.050 776.090 1.285.300 1.442.100
C09CA08 Olmesartan (Olmetec ®) 2.609.700 1.849.000 693.080 582.060 822.790
Totaal 13.488.040 12.431.830 12.309.700 16.224.580 16.635.690